Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant

Journal of Clinical Oncology

Volumn 25, Issue 5, 2007, Pages 513-516

  Einhorn, Lawrence H ^a   Brames, Mary J ^a   Juliar, Beth ^a   Williams, Stephen D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; PACLITAXEL; VINBLASTINE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SINGLE DRUG DOSE; TREATMENT RESPONSE; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; KAPLAN MEIER METHOD; MALE; NEOPLASM; OVARY TUMOR; PHASE 2 CLINICAL TRIAL; TESTIS TUMOR; TIME; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DEOXYCYTIDINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIANA; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PACLITAXEL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TESTICULAR NEOPLASMS; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33947532528     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.07.7271     Document Type: Article

References (27)

1. Einhorn LH: Treatment of testicular cancer: A new and improved model. J Clin Oncol 8:1777-1781, 1990
2. Einhorn LH: Testicular Cancer. Proc Natl Acad Sci U S A 99:4592-4595, 2002
3. Bosl GJ, Motzer RJ: Testicular germ cell cancer. N Engl J Med 337:242-253, 1997
4. Loehrer P, Nichols C, Weathers T, et al: Vinblastine plus ifosfamide plus cisplatin as initial salvage chemotherapy in recurrent germ cell tumor. J Clin Oncol 16:2500-2504, 1998
5. Kondagunta GV, Bacik J, Donadio A, et al: Combination of paclitaxel, ifosfamide and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23:6549-6555, 2005
6. Bhatia S, Abonour R, Porcu P, et al: High dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 18:3346-3351, 2000
7. Vaena DA, Abonour R, Einhorn LH: Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables. J Clin Oncol 21:4100-4104, 2003
8. Porcu P, Bhatia S, Sharma M, et al: Results of treatment after relapse from high-dose chemotherapy in germ cell tumors. J Clin Oncol 18:1181-1186, 2000
9. Miller JC, Einhorn LH: Phase II study of daily oral etoposide in refractory germ cell tumors. Semin Oncol 17:36-39, 1990
10. Murphy B, Breeden ES, Donohue JP, et al: Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 11:324-329, 1993
11. Motzer RJ, Bajorin DF, Schwartz LH, et al: Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 12:2277-2283, 1994
12. Nazario A, Amato R, Hutchinson L, et al: Paclitaxel in extensively pretreated nonseminomatous germ cell tumors. Urol Oncol 1:184-187, 1995
13. Bokemeyer C, Beyer J, Metzner B, et al: Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol 7:31-34, 1996
14. Sandler AB, Christous A, Fox S, et al: A phase II trial of paclitaxel in refractory germ cell tumors. Cancer 82:1381-1386, 1998
15. Einhorn LH, Stender MJ, Williams SD: Phase II trial of gemcitabine in refractory germ cell tumors. J Clin Oncol 17:509-511, 1999
16. Bokemeyer C, Gerl A, Schoffski P, et al: Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol 17:512-516, 1999
17. Einhorn L, Raghavan D, Kindler H, et al: A phase I trial of gemcitabine plus paclitaxel combination in patients with refractory solid tumors. Proc Am Soc Clin Oncol 17:207, 1998 (abstr 796)
18. Hinton S, Catalano P, Einhorn LH, et al: Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Co-operative Oncology Group. J Clin Oncol 20:1859-1863, 2002
19. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Cooper MA, Einhorn LH: Maintenance chemotherapy with daily oral VP-16 following salvage therapy in patients with germ cell tumors. J Clin Oncol 13:1167-1169, 1995
21. Motzer RJ, Mazumdar M, Bosl GJ, et al: High dose carboplatin, etoposide and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity. J Clin Oncol 14:1098-1105, 1996
22. Margolin K: High dose chemotherapy and stem cell support in the treatment of germ cell cancer. J Urol 169:1229-1233, 2003
23. Broun ER, Nichols CR, Kneebone P, et al: Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 117:124-128, 1992
24. Einhorn LH, Williams S, Abonour R: Salvage chemotherapy with high dose carboplatin + etoposide and peripheral blood stem cell transplant in patients with germ cell tumors. J Clin Oncol 24:228, 2006 (suppl; abstr 4542)
25. Kollmannsberger C, Rick O, Derigs HG, et al: Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: A study of the German Testicular Cancer Study Group. J Clin Oncol 20:2031-2037, 2002
26. Kollmannsberger C, Beyer J, Liersch R, et al: Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group. J Clin Oncol 22:108-114, 2004
27. Pectasides D, Pectasides M, Farmakis D, et al: Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: A phase II study. Ann Oncol 15:493-497, 2004